Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recurrence × Evoked Potentials × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Recurrence 1 Glioblastoma 1 Brain Neoplasms 1 Astrocytoma 1

Interventions

Cyclophosphamide 134 Dexamethasone 113 Rituximab 73 fludarabine 65 Lenalidomide 62 Cytarabine 59 Gemcitabine 55 Bortezomib 51 fludarabine phosphate 49 pembrolizumab 46 venetoclax 45 Etoposide 45 Paclitaxel 44 Carboplatin 44 Cisplatin 43 pomalidomide 41 Peripheral Blood Stem Cell Transplantation 38 Filgrastim 37 Radiotherapy 36 Bevacizumab 33 Melphalan 31 Busulfan 31 carfilzomib 30 Calcium Dobesilate 30 Cyclosporine 28 Methotrexate 27 Azacitidine 26 Temozolomide 25 Nivolumab 25 Mycophenolic Acid 25

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06273176 2024-02-22

RECMAP

Erasmus Medical Center

Astrocytoma, Brain Neoplasms, Glioblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡